Three-dimensional doppler ultrasonography in assessing nodal metastases and staging head and neck cancer

Objectives/Hypothesis This study built a simple prediction system by three‐dimensional (3D) Doppler ultrasonography to evaluate the metastases of cervical lymph nodes and the preoperative initial stage of head and neck cancer. Study Design Retrospective review of cervical lymph node ultrasound featu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Laryngoscope 2013-12, Vol.123 (12), p.3037-3042
Hauptverfasser: Lai, Yu-Shih, Kuo, Chun-Ying, Chen, Mu-Kuan, Chen, Hui-Chuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives/Hypothesis This study built a simple prediction system by three‐dimensional (3D) Doppler ultrasonography to evaluate the metastases of cervical lymph nodes and the preoperative initial stage of head and neck cancer. Study Design Retrospective review of cervical lymph node ultrasound features and prospective nodal staging of head and neck cancer. Methods One hundred thirty‐nine suspicious cervical lymph nodes, receiving 3D Doppler ultrasonography, were used to establish a predictive model. Then nodal metastasis was initially staged from 27 patients with head and neck cancer by this model. Results The prediction system was constructed by major (internal matting, vascularity pattern) and minor (age ≥ 40 years, short/long ratio ≥ 0.5) sign categories. Cervical lymph node was regarded as metastasis with the presence of one major and any of the other factors. The predictive model resulted in sensitivity of 91.9%, specificity of 88.2%, and accuracy of 89.2%. Then we evaluated the initial staging of patients with head and neck cancer by this model, and the rate of correct N staging was 92.6%. Conclusions According to this prediction system, 3D Doppler ultrasonography definitely provides a rapid and reliable method for initial staging of head and neck cancer. Level of Evidence 2b. Laryngoscope, 123:3037–3042, 2013
ISSN:0023-852X
1531-4995
DOI:10.1002/lary.24219